BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 25569814)

  • 21. Effects of surfactants on the magnetic properties of iron oxide colloids.
    Soares PI; Alves AM; Pereira LC; Coutinho JT; Ferreira IM; Novo CM; Borges JP
    J Colloid Interface Sci; 2014 Apr; 419():46-51. PubMed ID: 24491328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Iron Oxide Nanoparticle Based Contrast Agents for Magnetic Resonance Imaging.
    Shen Z; Wu A; Chen X
    Mol Pharm; 2017 May; 14(5):1352-1364. PubMed ID: 27776215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Facile synthesis of ultrasmall PEGylated iron oxide nanoparticles for dual-contrast T1- and T2-weighted magnetic resonance imaging.
    Hu F; Jia Q; Li Y; Gao M
    Nanotechnology; 2011 Jun; 22(24):245604. PubMed ID: 21508500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design of iron oxide-based nanoparticles for MRI and magnetic hyperthermia.
    Blanco-Andujar C; Walter A; Cotin G; Bordeianu C; Mertz D; Felder-Flesch D; Begin-Colin S
    Nanomedicine (Lond); 2016 Jul; 11(14):1889-910. PubMed ID: 27389703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contrast agents: magnetic resonance.
    Burtea C; Laurent S; Vander Elst L; Muller RN
    Handb Exp Pharmacol; 2008; (185 Pt 1):135-65. PubMed ID: 18626802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel magnetic iron oxide nanoparticles coated with poly(ethylene imine)-g-poly(ethylene glycol) for potential biomedical application: synthesis, stability, cytotoxicity and MR imaging.
    Schweiger C; Pietzonka C; Heverhagen J; Kissel T
    Int J Pharm; 2011 Apr; 408(1-2):130-7. PubMed ID: 21315813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Large-scale synthesis of uniform and extremely small-sized iron oxide nanoparticles for high-resolution T1 magnetic resonance imaging contrast agents.
    Kim BH; Lee N; Kim H; An K; Park YI; Choi Y; Shin K; Lee Y; Kwon SG; Na HB; Park JG; Ahn TY; Kim YW; Moon WK; Choi SH; Hyeon T
    J Am Chem Soc; 2011 Aug; 133(32):12624-31. PubMed ID: 21744804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Magnetic iron oxide nanoparticles for biomedical applications.
    Laurent S; Bridot JL; Elst LV; Muller RN
    Future Med Chem; 2010 Mar; 2(3):427-49. PubMed ID: 21426176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fe
    Lak A; Cassani M; Mai BT; Winckelmans N; Cabrera D; Sadrollahi E; Marras S; Remmer H; Fiorito S; Cremades-Jimeno L; Litterst FJ; Ludwig F; Manna L; Teran FJ; Bals S; Pellegrino T
    Nano Lett; 2018 Nov; 18(11):6856-6866. PubMed ID: 30336062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Water-dispersible sugar-coated iron oxide nanoparticles. An evaluation of their relaxometric and magnetic hyperthermia properties.
    Lartigue L; Innocenti C; Kalaivani T; Awwad A; Sanchez Duque Mdel M; Guari Y; Larionova J; Guérin C; Montero JL; Barragan-Montero V; Arosio P; Lascialfari A; Gatteschi D; Sangregorio C
    J Am Chem Soc; 2011 Jul; 133(27):10459-72. PubMed ID: 21604803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation of magnetic iron oxide nanoparticles for hyperthermia of cancer in a FeCl₂-NaNO₃-NaOH aqueous system.
    Li Z; Kawashita M; Araki N; Mitsumori M; Hiraoka M; Doi M
    J Biomater Appl; 2011 Mar; 25(7):643-61. PubMed ID: 20207773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Magnetic resonance relaxation properties of superparamagnetic particles.
    Gossuin Y; Gillis P; Hocq A; Vuong QL; Roch A
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(3):299-310. PubMed ID: 20049798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Iron oxide nanoparticle-containing microbubble composites as contrast agents for MR and ultrasound dual-modality imaging.
    Liu Z; Lammers T; Ehling J; Fokong S; Bornemann J; Kiessling F; Gätjens J
    Biomaterials; 2011 Sep; 32(26):6155-63. PubMed ID: 21632103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ultrasmall water-soluble metal-iron oxide nanoparticles as T1-weighted contrast agents for magnetic resonance imaging.
    Zeng L; Ren W; Zheng J; Cui P; Wu A
    Phys Chem Chem Phys; 2012 Feb; 14(8):2631-6. PubMed ID: 22273844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biocompatibility and proteomic profiling of DMSA-coated iron nanocubes in a human glioblastoma cell line.
    Ulanova M; Gloag L; Kim CK; Bongers A; Kim Duong HT; Gooding JJ; Tilley RD; Sachdev PS; Braidy N
    Nanomedicine (Lond); 2024 Feb; 19(4):303-323. PubMed ID: 38270934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LAPONITE® nanodisk-"decorated" Fe
    Basina G; Diamantopoulos G; Devlin E; Psycharis V; Alhassan SM; Pissas M; Hadjipanayis G; Tomou A; Bouras A; Hadjipanayis C; Tzitzios V
    J Mater Chem B; 2022 Jul; 10(26):4935-4943. PubMed ID: 35535802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ferrimagnetic nanocrystal assemblies as versatile magnetic particle hyperthermia mediators.
    Sakellari D; Brintakis K; Kostopoulou A; Myrovali E; Simeonidis K; Lappas A; Angelakeris M
    Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():187-93. PubMed ID: 26478302
    [TBL] [